Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure

BACKGROUND: The safety of once-daily (qd) dosing of valsartan in heart failure (HF) patients is not known. HYPOTHESIS: This 10-week, double-blind trial examined the relative safety and efficacy of valsartan administered qd versus twice-daily (bid). METHODS: HF patients (NYHA class II–III) receiving...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Anand, Inder S, Deswal, Anita, Kereiakes, Dean J, Purkayastha, Das, Zappe, Dion H
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2010
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2922305/
https://ncbi.nlm.nih.gov/pubmed/20730060
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker